Home        Sitemap        Contact us 
Arrien Pharmaceuticals is a small molecule targeted therapeutics drug discovery and development company working towards targeting kinase signaling pathways - A target class in treating Inflammation/Autoimmune, Multiple Sclerosis, Psoriasis, Cancer (Ovarian, Breast, Prostate, DLBCL and Lung Diseases). The Arrien Pharmaceuticals successfully applied proprietary platform to successfully discover a portfolio of uniquely identified IND ready stage programs.

Arrien Pharmaceuticals completed ARN-6039 Phase 1 clinical trials, a Phase 2 studies underway and in addition, two other programs; ARN-3261, ARN-4079 advanced in to IND enabling studies.

At its current stage Arrien Pharmaceuticals is funded by Founder of the company operating since January 2011. With this strong pre-clinical pipeline and clear exit strategy we are looking for the investment for the both pre-clinical and clinical stage of development for the year 2016.
Arrien Pharmaceuticals seeking:
  • Investment on our First-in-Class Targeted Therapeutics
  • Collaborations, Partnering and out licensing both at pre-clinical and clinical stage of development
We will be glad to share the non-confidential summary overview.
For more information contact:
Tel (Off): 801-285-7427
Tel (Direct): 801-349-5355
Email: hari@arrienpharma.com
Copyright © 2011, Arrien Pharmaceuticals, LLC. All rights reserved.